Skip to main content

Repetitive transcranial magnetic stimulation in the treatment of
obsessive-compulsive disorders: Double blind randomized clinical trial

Research Authors
Khaled A.M. Elbeh, Yasser M.B. Elserogy, Hossam E. Khalifa, Mohamed A. Ahmed,
Mahmoud H. Hafez, Eman M. Khedr
Research Journal

Psychiatry Research
Research Publisher
Elsevier
Research Rank
1
Research Vol
238
Research Website
Science direct, pubmed-indexed-medline
Research Year
2016
Research_Pages
264–269
Research Abstract

Repetitive transcranial magnetic stimulation (rTMS) has become widely used as a therapeutic tool in
psychiatric research. Theaim of this study was to evaluate the impact of different frequencies of rTMS
over right dorsolateral prefrontal cortex (DLPFC) in OCD. Forty five patients with OCD participated in the
study. Patients were evaluated using: Yale-Brown obsessive compulsive scale (Y-BOCS), Hamilton Anxiety
Rating Scale (HAM-A), and Clinical Global Impression-Severity scale (CGI-S). They were randomly classified
into three groups: 1st group received 1 Hz rTMS; 2nd group received 10 Hz rTMS; and 3rd group
received sham stimulation all at 100% of the resting motor threshold for 10 sessions. They were followed
up after the last treatment session and 3 months later. There was a significant “time”“group” interaction
for 1 Hz versus Sham but not for 10 Hz versus Sham. 1 Hz versus 10 Hz groups showed a significant
interaction for Y-BOCS and HAM-A (P¼0.001 and 0.0001 respectively). 1 Hz rTMS has a greater
clinical benefit than 10 Hz or Sham. There was also a significantly larger percentage change in GCI-S in
the 1 Hz group versus either 10 Hz or sham. We conclude that 1 Hz-rTMS, targeting right DLPFC is a
promising tool for treatment of OCD.